Possible Novel Therapy for Malignant Gliomas with Secretable Trimeric TRAIL

Malignant gliomas are the most common primary brain tumors. Despite intensive clinical investigation and many novel therapeutic approaches, average survival for the patients with malignant gliomas is only about 1 year. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Moonsup, Kwon, Yong-Sam, Park, Soon-Hye, Kim, Chae-Young, Jeun, Sin-Soo, Song, Kang-Won, Ko, Yong, Robbins, Paul D., Billiar, Timothy R., Kim, Byong-Moon, Seol, Dai-Wu
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2641005/
https://www.ncbi.nlm.nih.gov/pubmed/19229339
http://dx.doi.org/10.1371/journal.pone.0004545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2641005/
https://www.ncbi.nlm.nih.gov/pubmed/19229339
http://dx.doi.org/10.1371/journal.pone.0004545

Ejemplares similares